Integrated Care Story Series

Integrated Care Stories Series This series is intended to help health policy and other audiences understand how the elements of Kaiser Permanente's integrated care model combine to support better health and health care. The series includes: Overview: Kaiser Permanente's Integrated…

Reflections on the perils and promise of telehealth

Last month I had an opportunity to speak at a Kaiser Permanente Institute for Health Policy forum and it sparked an important conversation about the power and potential risks of telehealth. The field has advanced in many ways over the last…

Housing for health Covid-19 response

Supporting safe, stable housing during the Covid-19 pandemic. This brief details how Kaiser Permanente accelerated efforts to increase affordable housing, address homelessness, and advance health equity in the communities we serve during the Covid-19 pandemic. Download the brief.

Addressing housing affordability and health

Safe, stable housing is essential to a person’s health. This brief details how Kaiser Permanente is supporting efforts to end homelessness and expand access to affordable housing by making impact investments, catalyzing innovation through partnerships, and shaping public policy. Download…

Addressing racial disparities in health care delivery (Part 2)

With COVID-19 cases still high and the Biden-Harris administration newly in place, it has never been more important to acknowledge and address racial disparities that are being exacerbated by the pandemic. In a series of blogs and interviews, Kaiser Permanente…

Priti Krishtel

Building a bigger table for a more equitable drug development system

On December 7, 2020, the Kaiser Permanente Institute for Health Policy hosted the first of a 2-part virtual forum examining racial equity in the drug development system, including during initial investments and research, patent and regulatory processes, supplier and physician…

Biosimilars at Kaiser Permanente

Biosimilars play a critical role in lowering drug prices. Kaiser Permanente successfully uses biosimilars to improve affordability for our members. We are eager to share best practices and work with policymakers to help facilitate a more competitive market for biologic…

Get ready to vote 

Voting is the cornerstone of our representative democracy.  In voting, citizens select who will make critical decisions that influence our health and lives, on topics like health coverage, education, and the environment.  American history has been a difficult struggle to…

The Medicaid Drug Rebate Program and the impact of “best price” rules

The Medicaid Drug Rebate Program (MDRP) requires pharmaceutical manufacturers to issue rebates to Medicaid for covered outpatient drugs. When they offer prescription drug  benefits, Medicaid programs must cover nearly all drugs, potentially reducing Medicaid’s leverage to negotiate discounts. Policymakers created…